Home > Insider Trading > Filing (0001179110-19-001833)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	Biological Products, (No Disgnostic Substances) (2836)	043561634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1716468	M. Anthony Manning	C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-02-12	133	$12.77	63,167	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2019-02-11	106,000	$0.00	106,000	$12.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
106,000		2029-02-11	No	4	A	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
The stock option will vest and become exercisable with respect to 26,500 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. All vesting is subject to Anthony Manning's continued service to the Company through the applicable vesting date.